BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Business

  Avedro, Inc. Appoints C. Evan Ballantyne as Chief Financial Officer

  September 28, 2011

   · 

  1 min read
• Business

  AB SCIEX QTRAP Technology Assists Yale University Researchers to Engineer a Phosphoprotein

  September 28, 2011

   · 

  1 min read
• Business

  Achaogen Appoints Chief Medical Officer Kenneth Hillan to Chief Executive Officer

  September 28, 2011

   · 

  3 min read
• Pharm Country

  Fibrocell Science, Inc.’s LAVIVTM (azficel-T) Wins a 2011 Allure Best of Beauty Award

  September 28, 2011

   · 

  1 min read
• Deals

  Simulations Plus Bid for Assets of Entelos, Inc. Not Selected

  September 28, 2011

   · 

  1 min read
• Drug Development

  Rexahn Pharmaceuticals, Inc. Completes Patient Enrollment for Archexin Phase II Clinical Trial in Metastatic Pancreatic Cancer

  September 28, 2011

   · 

  1 min read
• Business

  Intuitive Surgical, Inc. Third Quarter, 2011 Earnings Conference Call

  September 28, 2011

   · 

  1 min read
• Drug Development

  Halozyme Therapeutics, Inc. Begins Clinical Trial with HTI-501 in Women with Edematous Fibrosclerotic Panniculopathy

  September 28, 2011

   · 

  3 min read
• Drug Development

  YM BioSciences Initiates Phase II BID Trial with CYT387 in Myelofibrosis

  September 28, 2011

   · 

  5 min read
• Drug Development

  Adamas Pharmaceuticals Initiates a Phase 2/3 Clinical Study of ADS-5102 for Parkinson’s Disease

  September 28, 2011

   · 

  4 min read